AP NEWS

Malaria Rapid Diagnostics Devices: Worldwide Markets, 2019 to 2023 with Abbott, bioMerieux, Bio-Rad Laboratories, QIAGEN, and Sight Diagnostics Dominating - ResearchAndMarkets.com

February 13, 2019

DUBLIN--(BUSINESS WIRE)--Feb 13, 2019--The “Global Malaria Rapid Diagnostics Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The malaria rapid diagnostics devices market will register a CAGR of over 5% by 2023.

The growing incidence of malaria in countries has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and can help in better diagnosis. The number of cases of malaria is higher in Africa and Southeast Asian countries because of poverty, the lack of healthcare infrastructure, and less knowledge about parasitic infectious diseases.

The growing incidence of malaria is resulting in an increasing demand for malaria diagnostic that provide rapid results. Many countries are promoting the use of malaria rapid diagnostic products such as systems and rapid test kits to facilitate early diagnosis. Therefore, growing incidence of malaria will drive the overall market growth.

Product launches

Companies are focusing on strengthening their market positions and to expand their product portfolio by offering different types of malaria rapid diagnostic products, including assays, tests, and kits. Also, many companies are receiving pre-market approval for its product which in turn will also drive the market growth.

Inaccuracy in rapid diagnostics tests

Inaccuracy and inconsistency in rapid diagnostic test results hinder the adoption of malaria rapid diagnostic devices. The adoption of rapid diagnostic products has increased as they provide rapid test results.

However, inaccurate test results (false-negative and false-positive results) can lead to misdiagnosis and wrong treatment. Regulatory bodies have no specific guidelines on how to conduct the rapid diagnostic tests.

Competitive Landscape

The malaria rapid diagnostics devices market appears to be moderately fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Players

Abbott bioMerieux Bio-Rad Laboratories QIAGEN Sight Diagnostics

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Comparison by product Consumables - Market size and forecast 2018-2023 Systems - Market size and forecast 2018-2023 Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic comparison ROW - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 North America - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

Strategic alliances Presence of government funding and investments Growing demand towards non-invasive products

PART 12: VENDOR LANDSCAPE

Overview Landscape disruption Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Abbott bioMerieux Bio-Rad Laboratories QIAGEN Sight Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/hzhhlq/malaria_rapid?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190213005424/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/13/2019 08:36 AM/DISC: 02/13/2019 08:36 AM

http://www.businesswire.com/news/home/20190213005424/en

AP RADIO
Update hourly